Navigation Links
Acne Treatment Brand, Probiotic Action, Comments on the Use of a Virus to Treat Acne

(PRWEB) February 27, 2013

On Feb 27, 2013, acne treatment company, Probiotic Action, comments on UCLA and University of Pittsburgh’s suggestion of a natural virus living on our skin being used to treat acne breakouts.

According to Medical News Today, scientists at the University of California, Los Angeles and the University of Pittsburgh are attempting to use a naturally-occurring virus that feeds on Propionibacterium acnes, a bacterium growing in human pores that cause acne outbreaks. They intend to extract these viruses in the hopes of creating new methods for combating this affliction.

The need for a new way to combat acne has come, partially, due to traditional preventative measures no longer working as effectively. Dr. Jenny Kim, Director of UCLA’s Clinic for Acne, Rosacea, and Aesthetics, comments on this in Medical News Today. She discusses how various strains of acne will build up immunities to conventional methods of preventative treatments, such as the antibiotic, tetracycline. She also went into detail on the potentially scarring consequences of acne outbreaks and how imperative it is to find alternative forms of treatment.

Adult acne treatment company, Probiotic Action, comments on this new research venture. According to Fernando Perez, a representative of Probiotic Action, “Regardless of the field, looking to new research materials and experimenting is the only way to improve, and that is no different in regards to acne prevention.” He continued, “Utilizing naturally-occurring viruses instead of potentially harmful chemicals shows a concern for those that suffer from acne breakouts. We hope for success from this line of research and hope it opens up new methods for combating acne breakouts.”

Probiotic Action is an advanced acne treatment that uses a topical probiotic containing the “good bacteria” that is naturally found on healthy human skin. By using probiotics, Probiotic Action is an effective treatment that restores the normal bacteria content on skin. Probiotic Action will successfully clear skin while protecting skin against bad bacteria, free radicals, and pollutants.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
2. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
3. Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain
4. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
5. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
6. Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A
7. SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma
8. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
9. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
10. Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7)
11. Biotech Firm Spun Off from Childrens Hospital Raises $7 Million to Advance Magnetic-Based Vascular Treatment
Post Your Comments:
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... ( ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... announced today it will be hosting a Webinar titled, “Pathology is going digital. ... Associates , on digital pathology adoption best practices and how Proscia improves lab ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... Oct. 10, 2017 International research firm Parks Associates ... speak at the TMA 2017 Annual Meeting , October 11 in ... the residential home security market and how smart safety and security products ... Parks Associates: Smart ... "The residential security market ...
Breaking Biology Technology:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):